Artificial Intelligence (AI) in Drug Discovery Market Trends Disrupting Traditional R&D
The integration of Artificial Intelligence (AI) into drug discovery processes is revolutionizing the pharmaceutical industry. According to Fortune Business Insights, the global AI in drug discovery market was valued at USD 3.00 billion in 2022 and is projected to reach USD 7.94 billion by 2030, exhibiting a CAGR of 12.2% during the forecast period. This growth is driven by the increasing need for efficient drug development processes and the rising prevalence of chronic diseases worldwide.
-
Follow
-
0
-
Embed
-
Share
-
Upload
